Table 1.
Demographic and clinical data | Number (%) |
---|---|
Total number of study population, N | 83 |
Age in years, median (range) | 50 (18–72) |
Sex (male) | 42 (50.6) |
Occupational status | |
Student | 5 (6) |
Government employee | 18 (21.7) |
Merchant | 11 (13.3) |
Farmer | 33 (39.8) |
Private work | 12 (14.5) |
None | 4 (4.8) |
Level of education | |
Illiterate | 42 (50.6) |
Primary school | 18 (21.7) |
Secondary school | 13 (15.7) |
College/university | 10 (12) |
Site of cancer | |
Genitourinary cancer | 21 (25.3) |
Gastrointestinal cancer | 19 (22.9) |
Breast cancer | 18 (21.7) |
Head and neck cancer | 6 (7.2) |
Bronchopulmonary cancer | 4 (4.8) |
Follicular lymphoma | 4 (4.8) |
Cancer of unknown primary | 4 (4.8) |
Others | 7 (8.4) |
Tumor stage | |
Stage 1 | 7 (8.4) |
Stage 2 | 20 (24.1) |
Stage 3 | 37 (44.6) |
Stage 4 | 19 (22.9) |
Metastasis (present) | 19 (22.9) |
Hx of cancer treatment modality | |
Chemotherapy | 61 (73.5) |
Surgery | 5 (6) |
Combination | 17 (20.5) |
Comorbidity (present) | 16 (19.3) |
Number of all medications prescribed, mean ± SD | 5.98 (±1.19) |
Number of analgesics prescribed, median (range) | 0 (0,3) |
Types of analgesic | |
No analgesics | 50 (60.2) |
Nonopioids ± adjuvant | 15 (18.1) |
Weak opioids ± nonopioids ± adjuvant | 14 (16.9) |
Strong opioids ± nonopioids ± adjuvant | 4 (4.8) |
Hx of any pain (yes) | 71 (85.5) |
Types of pain (N = 76) | |
Nociceptive pain | 33 (43.4) |
Neuropathic pain | 17 (21.7) |
Mixed | 26 (34.9) |